PON1’s antioxidant activity, its presence in both plasma and CSF [28,149,150,151], and the documented protein localization in certain regions of the brain suggest that PON1 could play a role in the pathogenesis of AD and other neurodegenerative diseases [152]. Here, PON1 is linked to Alzheimer disease.